Ameriprise’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.25M | Buy |
|
|||||
|
2025
Q2 | $696K | Sell |
|
|||||
|
2025
Q1 | $923K | Sell |
|
|||||
|
2024
Q4 | $712K | Sell |
|
|||||
|
2024
Q3 | $619K | Sell |
|
|||||
|
2024
Q2 | $495K | Sell |
|
|||||
|
2024
Q1 | $2.11M | Buy |
|
|||||
|
2023
Q4 | $1.22M | Sell |
|
|||||
|
2023
Q3 | $1.09M | Sell |
|
|||||
|
2023
Q2 | $1.55M | Buy |
|
|||||
|
2023
Q1 | $928K | Sell |
|
|||||
|
2022
Q4 | $758K | Hold |
|
|||||
|
2022
Q3 | $890K | Buy |
|
|||||
|
2022
Q2 | $638K | Sell |
|
|||||
|
2022
Q1 | $1.07M | Buy |
|
|||||
|
2021
Q4 | $168K | Buy |
|
|||||
|
2021
Q3 | $118K | Sell |
|
|||||
|
2021
Q2 | $198K | Buy |
|
|||||
|
2021
Q1 | $197K | Buy |
|
|||||
|
2020
Q4 | $49K | Sell |
|
|||||
|
2020
Q3 | $101K | Buy |
|